Surgery Partners revises HealthSpan merger to $25 per share

Surgery Partners Inc. (SGRY) revised its merger agreement with HealthSpan Partners, raising the acquisition price to $25 per share, up from previous terms. The deal, valued at up to $6.0 billion, includes potential additional payments if closed after March 1, 2027. The board recommends stockholder approval, despite a higher third-party offer. The merger is expected to close in Q1 2027, subject to approvals.

Original reporting
Published Nov 9, 2026, 1:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 1:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMergers & acquisitions
Primary signal
$SGRY
Bullish
high confidence
Mentioned
$SGRY
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$SGRYBullishHigh
01

Why it matters

The amendment improves shareholder value and may trigger a short‑cover rally, while also highlighting the competitive landscape with a higher third‑party offer.

02

Market read

The deal amendment is a material M&A development for SGRY, likely influencing its share price and setting a precedent for similar healthcare transactions.

03

What to watch

Potential competition from the unsolicited $28 per share third‑party bid could reignite bidding dynamics.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Surgery Partners (NASDAQ:SGRY) is a provider of outpatient surgery facilities. It has been pursuing a merger with HealthSpan Partners, backed by Bain Capital, with an original price lower than the newly announced $25 per share.

Company-level read

Ticker impact

$SGRYBullishHigh confidence
Context

Surgery Partners announced an amendment to its merger agreement with HealthSpan, raising the cash offer to $25 per share, a material change to the pending deal.

Expected impact

likely upward pressure as the market prices in the increased offer

Evidence & confidence

The amendment raises the per‑share price and adds a post‑closing cash kicker, making the transaction more attractive to shareholders.

Market effects

The amendment may set a higher valuation benchmark for other specialty surgery and healthcare M&A targets.

US healthcare M&A activity could see increased investor interest following this deal upgrade.

Limited to US healthcare sector; no broader macro impact.

Counterpoint

If regulatory or closing risks materialize, the higher offer may not translate into price gains.

Key entities

  • Surgery Partners Inc.

    US‑listed operator of outpatient surgery centers, ticker SGRY.

  • HealthSpan Partners

    Target of the merger, financed by cash and new debt.

  • Bain Capital Private Equity

    Current 39% shareholder of Surgery Partners, supporting the merger.

Related articles

$SGRYMed

Surgery Partners: Q3 Earnings Snapshot

Surgery Partners Inc. (SGRY) reported a Q3 loss of $21.1 million, or 16 cents per share, with adjusted earnings of 16 cents per share. The company's revenue was $815.3 million. The Tennessee-based surgical facilities operator provided these financial results on Monday.

$SGRYHighAI 8/10

SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2026 RESULTS

Surgery Partners, Inc. (SGRY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2026 RESULTS BRENTWOOD, Tenn., November 9, 2026 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced re